Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus’ replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
That experience moved Hurley to seek out PrEP, shorthand for preexposure prophylaxis. The antiretroviral medication greatly ...
In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
A randomized clinical trial led by Johns Hopkins researchers finds that giving patients a next-day HIV viral load (VL) test ...
A majority (91%) of HIV patients who received care through the Ryan White HIV/AIDS Program were virally suppressed in 2024, according to a new Health Resources and Services Administration (HRSA) ...
HIV is a lifelong infection that affects many people. People with HIV take many different types of medicines to help control their condition and to prevent the infection from developing into AIDS.
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
The US government paused all foreign assistance in January 2025. This abrupt decision affected the delivery of life-saving ...
News-Medical.Net on MSN
Expanded HIV treatment dramatically reduced orphanhood rates in Uganda
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai, Uganda, ...
Pharma stocks are back in focus as obesity drugs, HIV prevention and biotech deal activity shape the outlook heading into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results